Supplemental material
Open access
773
Views
0
CrossRef citations to date
0
Altmetric
Report
Alternative splicing for tuneable expression of protein subunits at desired ratios
Christel Aebischer-Gumya Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Pierre Morettia Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Timothee Brunstein Laplacea Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Jana Franka Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Ysaline Granda Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Farid Mosbaouia Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Emilie Hilya Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Anna Galeaa Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Megane Peltreta Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Carole Estoppeyb Antibody Engineering, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
, Daniel Ayoubc Analytical Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, Switzerlandhttps://orcid.org/0000-0001-6433-9917View further author information
, Roberto Giovanninid Process Sciences, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandView further author information
& Martin Bertschingera Drug Substance Development, Ichnos Sciences SA (formerly Glenmark Pharmaceuticals SA), La Chaux-de-Fonds, SwitzerlandCorrespondence[email protected]
View further author information
show allView further author information
Article: 2342243
|
Received 16 Jun 2023, Accepted 09 Apr 2024, Published online: 22 Apr 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.